Yale University

Effect of persistent moderate viremia on disease progression during HIV therapy.

TitleEffect of persistent moderate viremia on disease progression during HIV therapy.
Publication TypeJournal Article
Year of Publication2004
AuthorsRaffanti, Stephen P., Jennifer S. Fusco, Beth H. Sherrill, Nellie I. Hansen, Amy C. Justice, Richard D'Aquila, Wendy J. Mangialardi, and Gregory P. Fusco
Corporate AuthorsCollaborations in HIV Outcomes Research/United States Project
JournalJournal of acquired immune deficiency syndromes (1999)
Volume37
Issue1
Pagination1147-54
Date Published2004 Sep 1
ISSN1525-4135
KeywordsAdult, Anti-HIV Agents, CD4 Lymphocyte Count, Cohort Studies, Disease Progression, Drug Therapy, Combination, Female, HIV Infections, HIV-1, Humans, Male, Proportional Hazards Models, Reverse Transcriptase Inhibitors, RNA, Viral, United States, Viral Load, Viremia
AbstractAlthough highly active antiretroviral therapy has been shown to lower plasma HIV-1 RNA in HIV infection, many patients do not reach the target goal of undetectable viremia. We evaluated whether risk of clinical progression varies by level of viral suppression achieved.
Alternate JournalJ. Acquir. Immune Defic. Syndr.

External Links